Patents by Inventor Scott W. Umlauf

Scott W. Umlauf has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Deletion Mutants of Flagellin and Methods of Use
    Publication number: 20160193329
    Abstract: Compositions that include at least a portion of a flagellin and an antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to infection.
    Type: Application
    Filed: November 4, 2015
    Publication date: July 7, 2016
    Inventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
  • Deletion mutants of flagellin and methods of use
    Patent number: 9211320
    Abstract: Compositions that include at least a portion of a flagellin and an antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to infection.
    Type: Grant
    Filed: December 17, 2014
    Date of Patent: December 15, 2015
    Assignee: VaxInnate Corporation
    Inventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
  • Deletion mutants of flagellin and methods of use
    Patent number: 9205138
    Abstract: Compositions that include Toll-like Receptor 5 agonists and at least a portion of at least one viral antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to viral infection.
    Type: Grant
    Filed: December 16, 2014
    Date of Patent: December 8, 2015
    Assignee: VaxInnate Corporation
    Inventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
  • Deletion Mutants of Flagellin and Methods of Use
    Publication number: 20150110832
    Abstract: Compositions that include Toll-like Receptor 5 agonists and at least a portion of at least one viral antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to viral infection.
    Type: Application
    Filed: December 16, 2014
    Publication date: April 23, 2015
    Inventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
  • Deletion Mutants of Flagellin and Methods of Use
    Publication number: 20150099859
    Abstract: Compositions that include at least a portion of a flagellin and an antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to infection.
    Type: Application
    Filed: December 17, 2014
    Publication date: April 9, 2015
    Inventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
  • Deletion mutants of flagellin and methods of use
    Patent number: 8932605
    Abstract: Compositions that include Toll-like Receptor 5 agonists and at least a portion of at least one viral antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to viral infection.
    Type: Grant
    Filed: October 15, 2010
    Date of Patent: January 13, 2015
    Assignee: VaxInnate Corporation
    Inventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, Ge Liu
  • DELETION MUTANTS OF FLAGELLIN AND METHODS OF USE
    Publication number: 20110135680
    Abstract: Compositions that include Toll-like Receptor 5 agonists and at least a portion of at least one viral antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in a subject. Compositions can be associated with particles and employed in the methods in relatively low doses to provide protective immunity to viral infection.
    Type: Application
    Filed: October 15, 2010
    Publication date: June 9, 2011
    Inventors: Langzhou Song, Lynda G. Tussey, Alan R. Shaw, Robert S. Becker, Yi Zhang, Scott W. Umlauf, David N. Taylor, Ge Liu, Mark D. Yeager